Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

Figure 3

Risk assessment using the uPA/PAI-1 algorithm (UP) - all patients with G1 tumors were assessed low-risk, all patients with G3 tumors or ≤35 years were assessed high-risk. Patients with G2 tumors were assessed high-risk if uPA and/or PAI-1 were elevated above the validated cut-off levels.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us